Press Releases - 2019-10-31

Date	Title	Company
31-Oct-2019	The Importance of "Shop and Compare" During Medicare Annual Election Period	MDX Hawai'i
31-Oct-2019	Portage provides default status report	Portage Biotech Inc.
31-Oct-2019	Curis to Release Third Quarter Financial Results and Hold Conference Call on November 5, 2019	Curis, Inc.
31-Oct-2019	New England Journal of Medicine Publishes Results from Astellas' Phase 3 ADMIRAL Trial of XOSPATA® (gilteritinib) in Adult Patients with FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia(1)	Astellas Pharma US, Inc.
31-Oct-2019	November International Hyperhidrosis Awareness Month: No Sweat, No Stress With the miraDry Treatment	miraDry
31-Oct-2019	Watson-Marlow Fluid Technology Group’s puresu single-use tube assemblies offer reliable, sterile, customisable solutions for bioprocessing	Watson-Marlow Fluid Technology Group
31-Oct-2019	OB-002 Significantly Reduces Bone Metastasis in a Murine Model of Breast Cancer	Orion Biotechnology Canada, Ltd
31-Oct-2019	Vertex Announces European Medicines Agency Marketing Authorization Application Validation for VX-445 (Elexacaftor), Tezacaftor and Ivacaftor Combination Treatment in Cystic Fibrosis	Vertex Pharmaceuticals
31-Oct-2019	New Study Illustrates the Limitations of Compounded Thyroid Hormones	IBSA Pharma, Inc.
31-Oct-2019	Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA	Seneca Biopharma, Inc.
31-Oct-2019	Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA	Seneca Biopharma, Inc.
31-Oct-2019	RINVOQ™ (upadacitinib) Meets Primary and All Ranked Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis	AbbVie
31-Oct-2019	The Alliance for Regenerative Medicine Outlines Recommendations for Increasing the Number of European-Based ATMP Clinical Trials	Alliance for Regenerative Medicine
31-Oct-2019	Aenitis Technologies and the Direction Générale de l'Armement (DGA) sign a partnership to develop a new AMSC-S project with a 1,2 million euros budget	AENITIS TECHNOLOGIES
31-Oct-2019	Biophytis Files Protocol Amendment to Optimize the SARA-INT Phase 2b Clinical Trial for Sarcopenia	Biophytis SA
31-Oct-2019	Sirnaomics to Present Preclinical STP705 Data Suggesting Reduction in Liver Fibrosis at AASLD Liver Meeting	Sirnaomics, Inc.
31-Oct-2019	Bulletin from Moberg Pharma’s AGM on October 30th , 2019	Moberg Pharma
31-Oct-2019	ATP Assays Market Worth $315 Million by 2024 - Exclusive Report by MarketsandMarkets™	MarketsandMarkets
31-Oct-2019	Harley Street clinics to offer new brain stimulation treatment for depression	Flow Neuroscience
31-Oct-2019	First NHS patient receives Chiesi’s advanced-therapy-medicinal product, Holoclar▼ for moderate-to-severe limbal stem cell deficiency (LSCD) caused by chemical or thermal eye burns	Chiesi UK